Beneficial effects of the endothelin receptor antagonist bosentan on myocardial and endothelial injury following ischaemia/reperfusion in the rat
- 1 September 1995
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 283 (1-3) , 161-168
- https://doi.org/10.1016/0014-2999(95)00316-d
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Role of Endothelin During Reperfusion After Ischemia in Isolated Perfused Rat HeartJournal of Cardiovascular Pharmacology, 1994
- Intravenous administration of the endothelin-1 antagonist BQ-123 does not ameliorate myocardial ischaemic injury following acute coronary artery occlusion in the dogCardiovascular Research, 1994
- The endothelin-1 receptor antagonist BQ-123 reduces infarct size in a canine model of coronary occlusion and reperfusionCardiovascular Research, 1993
- Increased plasma level of endothelin-1-like immunoreactivity during coronary spasm in patients with coronary spastic anginaThe American Journal of Cardiology, 1991
- Presence of non‐selective type of endothelin receptor on vascular endothelium and its linkage to vasodilationFEBS Letters, 1991
- Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptorNature, 1990
- Cloning and expression of a cDNA encoding an endothelin receptorNature, 1990
- Endothelin/sarafotoxin receptor induced phosphoinositide turnover: Effects of pertussis and cholera toxins and of phorbol esterBiochemical and Biophysical Research Communications, 1990
- Ischaemia causes externalization of endothelin-1 binding sites in rat cardiac membranesBiochemical and Biophysical Research Communications, 1989
- Calcium antagonists and the ischemic myocardiumInternational Journal of Cardiology, 1987